BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18585456)

  • 1. Structures of TLR-ligand complexes.
    Jin MS; Lee JO
    Curr Opin Immunol; 2008 Aug; 20(4):414-9. PubMed ID: 18585456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of the toll-like receptor family and its ligand complexes.
    Jin MS; Lee JO
    Immunity; 2008 Aug; 29(2):182-91. PubMed ID: 18701082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural biology of the Toll-like receptor family.
    Kang JY; Lee JO
    Annu Rev Biochem; 2011; 80():917-41. PubMed ID: 21548780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures and recognition modes of toll-like receptors.
    Gao D; Li W
    Proteins; 2017 Jan; 85(1):3-9. PubMed ID: 27699870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensing of microbial molecular patterns by Toll-like receptors.
    Song DH; Lee JO
    Immunol Rev; 2012 Nov; 250(1):216-29. PubMed ID: 23046132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins.
    Carpenter S; O'Neill LA
    Biochem J; 2009 Jul; 422(1):1-10. PubMed ID: 19627256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two modes of ligand recognition by TLRs.
    Brodsky I; Medzhitov R
    Cell; 2007 Sep; 130(6):979-81. PubMed ID: 17889640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles for accessory molecules in microbial recognition by Toll-like receptors.
    Miyake K
    J Endotoxin Res; 2006; 12(4):195-204. PubMed ID: 16953972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR accessory molecules.
    Akashi-Takamura S; Miyake K
    Curr Opin Immunol; 2008 Aug; 20(4):420-5. PubMed ID: 18625310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of toll-like receptors.
    Gay NJ; Gangloff M
    Handb Exp Pharmacol; 2008; (183):181-200. PubMed ID: 18071660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of protein-protein interactions in Toll-like receptor function.
    Berglund NA; Kargas V; Ortiz-Suarez ML; Bond PJ
    Prog Biophys Mol Biol; 2015 Oct; 119(1):72-83. PubMed ID: 26144017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogen recognition: TLRs throw us a curve.
    Kirk P; Bazan JF
    Immunity; 2005 Oct; 23(4):347-50. PubMed ID: 16226500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep.
    Kramer BW; Kallapur SG; Moss TJ; Nitsos I; Newnham JP; Jobe AH
    Innate Immun; 2009 Apr; 15(2):101-7. PubMed ID: 19318420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune sensing and activation of cell surface Toll-like receptors.
    Tapping RI
    Semin Immunol; 2009 Aug; 21(4):175-84. PubMed ID: 19493685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors in inflammation, infection and cancer.
    Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
    Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors, inflammation and cancer.
    Tsan MF
    Semin Cancer Biol; 2006 Feb; 16(1):32-7. PubMed ID: 16153858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond.
    Lahiri A; Das P; Chakravortty D
    Vaccine; 2008 Dec; 26(52):6777-83. PubMed ID: 18835576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR signaling by tumor and immune cells: a double-edged sword.
    Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
    Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
    Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
    Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.